The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Six out of 10 infants and newborns in Canada will have access to the protective antibody Beyfortus® for the first time this ...

RSV vaccination for infants and mothers should be administered either in the hospital or directly from a primary health-care ...

Beyfortus ® is the first immunization designed for all infants to help prevent RSV lower respiratory tract disease through their first RSV season. Beyfortus ® is also indicated for children up ...

Sanofi announced that Beyfortus (nirsevimab) will be broadly available for babies born in Ontario, Quebec, Nunavut, Northwest ...

As fall approaches, so does respiratory syncytial virus or RSV season. This year, there are more options for those most ...

A new government program will give pregnant mothers and newborns free access to RSV vaccines, a move that is expected to ...

The respiratory virus is the leading cause of hospitalisation for infants, with 12,000 babies admitted each year. Before next ...

Beyfortus, the new monoclonal antibody injection, similarly reduces the risk of RSV in infants for about five months—or one RSV season. In adults, the most frequently reported side effects have ...

Nationwide RSV immunisation program to keep 10,000 babies out of hospitalImmunisation advocates are heralding the Albanese Government's commitment to ...